Makes History with India’s First Human Telesurgery Trial, and Welcomes Dr. Fredric Moll, Father of Surgical Robotics as Board Member and Vice Chairman
- SSI Mantra 3 integrates cutting-edge advancements in robotic surgery, offering surgeons unparalleled precision and control for improved patient outcomes
- SS Innovations reinforces India’s position as a hub for technological innovation in healthcare
- Dr. Frederic H. Moll, the Founder of Intuitive Surgical, Inc., and Father of Surgical Robotics announces his joining SS Innovations International Inc., as a member of the Board of Directors and Vice-Chairman
Bhubaneswar: SS Innovations, the developer of India’s first Indigenous surgical robotic system- SSI Mantra, dedicated to making advanced robotic surgeries cost-effective and accessible to a global population, today launched SSI Mantra 3, which is the next generation, most advanced version of the Mantra surgical robot system. Alongside, it has achieved a historic feat in Indian medical science by completing the Nation’s maiden human trial in telesurgery, signifying a monumental leap in surgical robotics. The launch of SSI Mantra 3 underlines SS Innovations’ commitment to revolutionising healthcare by providing cutting-edge technology at affordable prices.
The new SSI Mantra 3 is highly advanced and is designed to enhance surgical precision, efficiency, and patient outcomes by integrating the latest advancements in robotic surgery, featuring 5 slimmer robotic arms and an immersive 3D HD headset which provides surgeons with unmatched optics and a vision cart that provides 3D 4K vision to the entire team for precision and control. Additionally, the cost-effective pricing of SSI Mantra 3 aims to make advanced surgical technologies more accessible to healthcare institutions across all regions of India and the world.
In a momentous stride forward, SS Innovations has successfully conducted India’s first human trial in telesurgery using the SSI Mantra Surgical Robot. This groundbreaking, flawless surgery was a robotic cholecystectomy that took place between the World Laparoscopy Hospital and the SSI Headquarters over a distance of 5 kilometresusing the seamless connectivity of Airtel’s fiberoptic network with no perceptible delay. The telesurgery trial signifies a major step forward in providing quality healthcare to remote areas, further aligning with the Make in India initiative by showcasing Indigenous innovation on a global stage.
In a notable step forward, Dr. Fredric Moll, widely regarded as the father of surgical robotics, and the visionary founder of Intuitive Surgical, has joined SS Innovations International Inc., as a Board Member and Vice Chairman. Dr. Moll has been a pivotal force in advancing robotic surgery and contributed significantly to the development of various groundbreaking robotic technologies that have contributed to the evolution of robotics in medicine. Dr. Moll’s addition to the leadership team of SS Innovations underscores the organisation’s commitment to excellence and innovation in the medical device industry.
Founder, Chairman and CEO, of SS Innovations, Dr Sudhir Srivastava, pioneer in robotic cardiac surgery and the brain behind the SSI Mantra System, popularly known as the Father of Surgical Robotics in India, reflects on this milestone: “Today marks a significant moment in our journey towards revolutionising and decentralising excellence in the healthcare industry. With the launch of SSI Mantra 3 and the successful completion of India’s first human trial in soft tissue telesurgery, we reaffirm our commitment to driving advanced innovation and accessibility in robotic surgeries. These achievements underline our belief in the power of our indigenous technology to transform healthcare across the globe. We are proud to contribute to the Make in India initiative and remain dedicated to advancing the boundaries of surgical excellence.”
SSI Mantra 3 allows for smaller fingertip-sized incisions, leading to less pain, minimal blood loss, reduced scarring, faster recovery, and shorter hospital stays. This most advanced surgical robotic system with its cost-effectiveness will make advanced robotic surgery more accessible to hospitals, doctors and the ultimate beneficiary, patients. The SSI Mantra 3 ensures unparalleled precision and efficiency across a wide range of multispecialty and the full spectrum of robotic cardiac surgery procedures.
